Digital Breast Tomosynthesis (DBT) Equipment Market Outlook

From 2023 to 2033, the global digital breast tomosynthesis (DBT) equipment market is projected to develop at a CAGR of 13.9%, reaching an estimated value of US$ 2,594.4 million. By 2033, the digital breast tomosynthesis (DBT) equipment market size is expected to attain US$ 9,495.1 million.

The digital breast tomosynthesis (DBT) equipment market expansion is correlated with the prevalence of breast cancer and the rising need for breast cancer screening and diagnosis. A cutting-edge technology called digital breast tomosynthesis or 3D breast tomosynthesis enables radiologists to diagnose breast cancer accurately.

Through computer reconstruction, a succession of 2-D photographs is used to produce a 3-D image of the women's breasts. Due to the high rate of accuracy it offers for diagnosing breast cancer in women with dense breasts, this technology is often used. Digital breast tomosynthesis has a significantly lower chance of producing incorrect results than traditional mammography, which creates 2-D digital images of the breast.

It is crucial to efficiently complete the diagnostic and screening because the incidence is fairly high, which may enhance the standard of patient care. This is very beneficial for the digital breast tomosynthesis (DBT) equipment market.

Key Highlights of the Digital Breast Tomosynthesis (DBT) Equipment Industry

  • Due to increased awareness and demand for advanced breast cancer screening, the digital breast tomosynthesis equipment market is expanding rapidly.
  • DBT equipment's technological developments foster digital breast tomosynthesis (DBT) equipment market expansion and enhance breast cancer early detection rates.
  • As healthcare providers attempt to improve diagnostic accuracy and lower false positives, DBT equipment adoption is rising globally.
  • Accessibility to advanced breast cancer screening is being improved by market growth for cost-effective DBT equipment solutions.
  • Market trends point to a move toward 3D mammography, with DBT equipment setting the standard in breast imaging.
Attributes Details
DBT Equipment Market Value for 2023 US$ 2,594.4 million
DBT Equipment Market Value for 2033 US$ 9,495.1 million
DBT Equipment Market CAGR from 2023 to 2033 13.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Tracking Trends of DBT Equipment Market From 2018 to 2022 and Predicting the Path From 2023 to 2033

The digital breast tomosynthesis (DBT) equipment market surged strongly, with a phenomenal 15.9% CAGR between 2018 and 2022. Early identification of breast cancer improves patients' prognosis and treatment effectiveness. The goal of numerous campaigns to increase knowledge about breast cancer and encourage early diagnosis at the national, regional, and local levels is to be led by governmental authorities, public organizations, business corporations, advocacy groups, and community organizations.

  • National Breast and Cervical Cancer Early Detection Program (NBCCEDP), run by the Centers for Disease Control and Prevention. It offers marginalized women without insurance access to affordable breast and cervical cancer screenings.
  • National Breast Cancer Foundation's commitment to the awareness campaigns of October's Breast Cancer Awareness Month is amplified, potentially boosting the market.
Historical CAGR 15.9%
Forecast CAGR 13.9%

Another motivating factor is technology, which has improved sensitivity and specificity in detecting breast cancer by lowering false positives and negatives and false negatives. Combining 2-D and 3-D mammography enables a thorough examination that helps find hidden breast tumors.

Given these elements, a solid 14.1% CAGR is anticipated for the global digital breast tomosynthesis (DBT) equipment market from 2023 to 2033, exhibiting significant growth opportunities.

Tomosynthesis Pioneers Imaging Technology in Cancer Care

The cancer industry also requires several technological improvements to keep up with the general healthcare business. Tomosynthesis is the only imaging technology to visualize the entire breast and detect the total radiation dosage, patient movements, image time, detector motion, and detector performance. It also has a comprehensive future biopsy capability for the lesions driving the breast tomosynthesis equipment market.

  • Researchers have determined that digital breast tomosynthesis has improved community breast cancer screening performance and identifies more invasive tumors, as reported in the article by the Radiological Society of North America.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Skyrocketing Prices of Market Stifle Medical Progress

The high equipment cost limits market expansion, particularly in developing nations. For various types and manufacturers, digital breast tomosynthesis equipment costs vary.

Priced between US$ 1,40,000 and US$ 2,75,000, the 3D models of Hologic Inc. and GE Healthcare's high-end equipment are available. The expensive cost of breast tomosynthesis equipment is a key problem for patients; it prevents healthcare practitioners from installing such equipment and leads to laborious diagnostic procedures. Due to these circumstances, the digital breast tomosynthesis (DBT) equipment market is predicted to increase slowly.

Soaring Breast Image Interpretation with AI and Machine Learning

Integration with AI and Machine Learning holds immense potential for digital breast tomosynthesis (DBT) equipment manufacturers. By incorporating AI and machine learning algorithms into DBT systems, digital breast tomosynthesis (DBT) equipment manufacturers can significantly enhance the interpretation of breast images. These technologies improve the accuracy of identifying abnormalities, reducing false positives and missed detections.

AI-driven software solutions aid radiologists in streamlining their workflow, making the diagnostic process more efficient. This improves patient outcomes by enabling earlier and more accurate diagnoses and boosts the overall appeal and competitiveness of DBT equipment in the rapidly evolving field of breast cancer screening and diagnosis.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Adjacent DBT Equipment Market

The digital mammography market and the breast imaging market have both been studied by Future Market Insights (FMI). The data depict the projected digital breast tomosynthesis equipment market growth from 2023 to 2033 in other markets. It showcases the potential for revenue in the additional markets shown below.

Digital Breast Tomosynthesis (DBT) Equipment Market:

Attributes Digital Breast Tomosynthesis Equipment Market
Value-based CAGR (2023 to 2033) 13.9%
Projected Market Value (2033) US$ 9,495.1 million
Market Trends
  • Artificial intelligence integration improves the diagnostic precision of DBT, supporting market expansion.
  • The adoption of DBT as the norm for breast imaging stimulates market growth.
Growth Factors
  • The adoption of 3D mammography technology fosters demand for DBT equipment globally.
  • Rising awareness and screening initiatives drive demand for DBT equipment in emerging regions.

Digital Mammography Market:

Attributes Digital Mammography Market
Value-based CAGR (2023 to 2033) 10.26%
Projected Market Value (2033) US$ 4.38 billion
Market Trends
  • Rising awareness of breast health issues and the value of routine tests.
  • Improvements in software systems are streamlining the workflow and interpretation of digital mammography.
Growth Factors
  • Cost-effective solutions are being promoted in the digital mammography industry by the move toward value-based healthcare.

Breast Imaging Market:

Attributes Breast Imaging Market
Value-based CAGR (2023 to 2033) 8.6%
Projected Market Value (2033) US$ 11.65 billion
Market Trends
  • The breast imaging industry is expanding due to rising digital mammography demand.
  • The market inflates as people become more aware of early breast cancer screening.
Growth Factors
  • Personalized breast cancer risk assessment tools are becoming a key trend.

Category-wise Outlook

3-D Equipment Revolutionizes the Digital Breast Tomosynthesis Equipment Market

The 3-D Equipment section is a prominent digital breast tomosynthesis (DBT) equipment market growth driver within the product type category. Comparing 3-D equipment to conventional 2-D equipment reveals various benefits. In addition to lowering false positives and enhancing early cancer diagnosis, it offers sharper and more detailed images. This cutting-edge technology is becoming increasingly popular with patients and medical professionals for breast cancer screening.

Leading Segment 3-D Equipment
Segment Share 62.3%

The accuracy of 3-D imaging has improved, and there is now less radiation exposure, making it a safer and more effective option. The demand for DBT equipment is increasing as people become more aware of the advantages of breast cancer screening. Regulatory approvals and reimbursement procedures fuel digital breast tomosynthesis (DBT) equipment market expansion. The effectiveness and innovation of the 3-D Equipment category continue to fuel digital breast tomosynthesis equipment market expansion.

The Hospitals Segment is a Strategic Choice for Digital Breast Tomosynthesis (DBT) Equipment Manufacturers

The primary end-user category for the digital breast tomosynthesis (DBT) equipment sales is the hospitals segment. Hospitals serve as the key diagnostic and therapeutic hubs for breast cancer, making them the ideal locations for cutting-edge breast imaging technology like DBT. Hospitals frequently have the money to invest in expensive medical technology, ensuring a constant demand for DBT systems.

Since hospitals are multidisciplinary settings, radiologists, oncologists, and surgeons can work together to provide comprehensive breast cancer care that uses the diagnostic accuracy provided by DBT.

Leading Segment Hospitals
Segment Share 64.9%

Hospitals frequently have the infrastructure to provide breast screening and diagnosis under one roof, improving patient care. Patient convenience and accessibility also play a vital role. Due to its congruence with clinical demands and financial capabilities, the hospital segment has attractive sales.

Country-wise Analysis

The United States Leads the Way in the Digital Breast Tomosynthesis Equipment Market

The United States shines out as a significant digital breast tomosynthesis (DBT) equipment market. The United States has a strong healthcare system and a high rate of breast cancer screenings, which drives demand for improved imaging technologies. The United States digital breast tomosynthesis (DBT) equipment market places a high value on technological innovation, creating a competitive environment that stimulates the creation and use of cutting-edge medical technology.

Attributes Details
Market Share 45.3%

The United States has a big population, including an aging population, which raises the importance of early breast cancer detection. Insurance coverage and reimbursement policies encourage DBT use, making therapy more accessible to a broader patient population. The medical research and regulatory organizations in the United States maintain stringent standards, increasing belief in DBT's efficacy and safety and fuelling its market expansion.

The United States is a significant player in the DBT equipment market due to factors including healthcare infrastructure, innovation, demographics, governmental support, and regulatory monitoring.

Augmenting Healthcare Infrastructure Elevates DBT Equipment Demand in China

China is a tremendously profitable digital breast tomosynthesis (DBT) equipment market. China's vast population of around 1.4 billion people translates into a large pool of potential patients, fuelling demand for sophisticated breast cancer screening technologies such as DBT. Rising breast cancer awareness and the necessity of early detection have increased Chinese women's willingness to undergo screenings, strengthening the DBT equipment market.

Attributes Details
Market CAGR 11.2%

The healthcare infrastructure in China is quickly expanding, with an increase in hospitals and diagnostic centers implementing cutting-edge medical technologies. The government's attempts to enhance healthcare access and insurance coverage drive DBT equipment uptake.

China's large population, improved healthcare infrastructure, increased awareness, and rising disposable budgets make it an extremely appealing market for DBT equipment manufacturers.

Developing Healthcare Facilities Fosters DBT Equipment Opportunities in India

Due to the rising incidence of breast cancer in India, there is a growing demand for better diagnostic tools, making DBT a key technology for early detection and precise diagnosis. The growing awareness of breast health and the significance of regular screenings among Indian women has spurred the adoption of DBT.

Attributes Details
Market CAGR 12.4%

With a growing middle-class population willing to invest in better healthcare, India's healthcare infrastructure is fast increasing. This, combined with government attempts to enhance healthcare access, creates a favorable atmosphere for DBT equipment manufacturers to prosper. Some firms' reasonable pricing and innovative financing methods make DBT more accessible to a wider range of healthcare facilities, including smaller clinics and hospitals.

India is a potential digital breast tomosynthesis (DBT) equipment market because of the country's expanding healthcare demands, increased awareness, improved infrastructure, and affordability issues.

Opportunities in the United Kingdom's DBT Equipment Market

The digital breast tomosynthesis (DBT) equipment market outlook for the United Kingdom is defined by rising demand for advanced breast imaging technology and a dedication to improving breast cancer detection and diagnosis. DBT, which provides superior imaging capabilities to standard mammography, is gaining traction in the United Kingdom's healthcare industry.

The National Health Service (NHS) has been actively introducing DBT into breast cancer screening programs to increase early detection rates and decrease false positives.

Attributes Details
Market CAGR 10.0%

The United Kingdom's strong research and development ecosystem, which includes cooperation between academia and industry, contributes to DBT equipment innovation and technological breakthroughs. Regulatory authorities such as the Medicines and Healthcare Products Regulatory Agency (MHRA) ensure product safety and efficacy, which increases market trust.

The United Kingdom is projected to have continuous investment and expansion in the DBT equipment market as breast cancer continues to be a leading health concern, providing possibilities for domestic and foreign producers to forge a presence in this changing market.

Competitive Analysis

The digital breast tomosynthesis equipment market is strongly competitive, with many businesses fighting for market share. Leading digital breast tomosynthesis equipment manufacturers use tactics like innovation, research and development investments, and collaborations to preserve their competitive advantage.

New digital breast tomosynthesis (DBT) equipment manufacturers are joining the market with creative solutions, escalating the rivalry and accelerating the development of DBT equipment. The rising demand for breast cancer screening options fuels the digital breast tomosynthesis (DBT) equipment industry's competitive dynamics.

Recent Advancements

Company Details
Bayer In January 2023, Bayer said it may buy Blackford Analysis Ltd. to help satisfy the growing demand for medical imaging and the shortage of radiologists. Encouraging innovation in radiology and integrating AI into clinical workflow essentially strives to improve patient quality of life.
University College London Hospitals (UCLH) Initiated by University College London Hospitals (UCLH) in January 2023, the first proton beam therapy trial for breast cancer to more precisely target radiotherapy beams for patients at risk for long-term heart problems. Proton beam therapy can help focus on giving breast tissue the right doses of radiation by reducing off-target radiation to the heart.
Whiterabbit Whiterabbit created the ACT program in August 2022, which uses images of digital breast tomosynthesis, or 3D mammography, to analyze breast cancer automatically.
Therapixel Therapixel secured EUR 15 million in Series B fundraising in May 2022 to increase its commercial footprint in the United States, offer new features for its MammoScreen platform, and push the limits of its reading tool for mammography.
Hologic, Inc. Hologic, Inc. declared the inauguration of its innovation hub in France in March 2022. With the addition of this facility, breast healthcare may benefit from improved ultrasound, interventional, and surgical options.
GE Healthcare GE Healthcare and Unilabs signed a partnership contract in April 2022. GE Healthcare provides X-rays, ultrasound, mammography, and MRI equipment with cutting-edge technology to Unilabs in Portugal.

Vital Digital Breast Tomosynthesis (DBT) Equipment Manufacturers

  • GE Healthcare
  • Siemens Healthineers
  • Hologic Inc.
  • Canon Medical
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Internazionale Medico Scientifica
  • PLANMED OY
  • Analogic Corporation
  • Trivitron Healthcare

Key Segments

By Product:

  • 3-D Equipment
  • 3-D Upgradation

By End User:

  • Hospitals
  • Diagnostic Centres

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Current Digital Breast Tomosynthesis (DBT) Equipment Market Valuation?

The market is to secure a valuation of US$ 2,594.4 million in 2023.

How Big Can the DBT Equipment Market Be by 2033?

The market is estimated to reach US$ 9495.1 million by 2033.

What is the Growth Potential of the Digital Breast Tomosynthesis Equipment Market?

Through 2033, the industry is anticipated to expand at a 13.9% CAGR.

What Was the Historical Outlook of The DBT Equipment Market?

From 2018 to 2022, the digital breast tomosynthesis equipment market recorded a 15.9% HCAGR.

Which Product Type Segment to Dominate in the Market?

The 3-D equipment sector is set to achieve a market share of 62.3%.

Which End User Segment to Lead the DBT Equipment Market?

A 64.9% market share is expected for the hospital sector.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. 3-D Equipment

        5.3.2. 3-D Upgradation

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Diagnostic Centres

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By End User

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. GE Healthcare

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Siemens Healthineers

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Hologic Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Canon Medical

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. FUJIFILM Holdings Corporation

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. General Electric Company

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Internazionale Medico Scientifica

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. PLANMED OY

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Analogic Corporation

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Trivitron Healthcare

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Mammography Market

March 2019

REP-GB-9040

August 2023

250 pages

Healthcare

Breast Imaging Market

May 2022

REP-GB-14796

343 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Digital Breast Tomosynthesis (DBT) Equipment Market